Court Approves BowFlex Inc. Purchase Agreement by Johnson Health Tech
April 15 2024 - 10:33PM
Business Wire
BowFlex Inc. (“BowFlex” or “the Company”) today announced that
the U.S. Bankruptcy Court for the District of New Jersey (the
“Court”) entered an order approving the sale of the Acquired Assets
pursuant to the terms of the previously announced Stalking Horse
Asset Purchase Agreement (“Purchase Agreement”) with Johnson Health
Tech Retail, Inc. (“Johnson Health Tech” and such order, the “Sale
Order”). Pursuant to the terms of the Purchase Agreement, Johnson
Health Tech has agreed to acquire substantially all of the
Company’s assets (the “Acquired Assets”) for $37,500,000 in cash,
less certain adjustments.
“We are pleased that the Court has approved this transaction
with Johnson Health Tech,” said Jim Barr, BowFlex Inc. Chief
Executive Officer. “Johnson Health Tech is among the world’s
largest and fastest-growing fitness equipment manufacturers and
home to some of the most respected brands in the fitness industry,
making them the right organization to lead BowFlex into its next
chapter.”
The transaction remains subject to customary closing conditions
and is expected to close on or around April 22, 2024.
Additional information about the asset sale and court-supervised
process is available online at
https://dm.epiq11.com/Bowflex, or by
contacting the Company’s Claims Agent, Epiq, at
BowflexInc@epiqglobal.com or by calling toll-free at (888) 311-7005
or +1 (971) 328-4573 for calls originating outside of the U.S.
Advisors
Sidley Austin LLP and Holland & Hart LLP are serving as
legal advisors to BowFlex. FTI Consulting, Inc. and FTI Capital
Advisors LLC have been retained as financial advisor and investment
banker to BowFlex to manage the sale process.
Forward-Looking Statements
This press release includes forward-looking statements
(statements which are not historical facts) within the meaning of
the Private Securities Litigation Reform Act of 1995. These
statements include, but are not limited to, express or implied
forward-looking statements relating to the Company’s statements
regarding the process and potential outcomes of the Company’s
Chapter 11 Cases, the Company’s expectations regarding the Stalking
Horse Asset Purchase Agreement, the Bankruptcy Court’s approval and
entry of the Sales Order, the anticipated closing and closing date
of the Asset Sale, and the anticipated proceeds from the Asset
Sale. You are cautioned that such statements are not guarantees of
future performance and that our actual results may differ
materially from those set forth in the forward-looking statements.
All of these forward-looking statements are subject to risks and
uncertainties that may change at any time. Factors that could cause
the Company’s actual expectations to differ materially from these
forward-looking statements also include: risks inherent in the
bankruptcy process, including the outcome of the Chapter 11 Cases;
the Company’s financial projections and cost estimates; the
Company’s ability to sell any of its assets; and the effect of the
Chapter 11 Cases on the Company’s business prospects, financial
results and business operations. The Company may not actually
achieve the plans, intentions or expectations disclosed in its
forward-looking statements, and you should not place undue reliance
on its forward-looking statements. Additional assumptions, risks
and uncertainties that could cause actual results to differ
materially from those contemplated in these forward-looking
statements are described in detail in our registration statements,
reports and other filings with the Securities and Exchange
Commission, including the “Risk Factors” set forth in our Annual
Report on Form 10-K, as supplemented by our quarterly reports on
Form 10-Q. Such filings are available on our website or at
www.sec.gov. We undertake no obligation to publicly update or
revise forward-looking statements to reflect subsequent
developments, events, or circumstances, except as may be required
under applicable securities laws.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240415596410/en/
Investor Relations: John Mills ICR, LLC 646-277-1254
John.Mills@icrinc.com
Media: Edelman Smithfield
bowflex@edelmansmithfield.com
Hanna Decker BowFlex Inc. hdecker@bowflex.com
BowFlex (NYSE:BFX)
Historical Stock Chart
From Feb 2025 to Mar 2025
BowFlex (NYSE:BFX)
Historical Stock Chart
From Mar 2024 to Mar 2025